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ABSTRACT
Background: Diabetes is a major health burden worldwide. There is a close association between albuminuria and 
development of stroke in diabetics. This study was conducted to determine the frequency of albuminuria among 
diabetic patients presenting with stroke
Methodology: This descriptive cross-sectional study was conducted in the department of Medicine, DHQ Teaching 
Hospital, Abbottabad, from 15th April to 15th October, 2017. All diabetic patients of either gender above age 20 who 
were admitted with stroke were included in the study on the basis on non-probability consecutive sampling. The data 
was collected through a structured pro forma and analysed using SPSS-16.
Results: A total of 147 cases fulfilling the inclusion and exclusion criteria were enrolled, among them 93(63.27%) 
were males and 54(36.73%) were females. Majority of the patients 54(36.73%) were between 41-50 years. 
Frequency of albuminuria among diabetic patients presenting with stroke was 35.37%(n=52).
 
Conclusion: The frequency of albuminuria is high among diabetic patients presenting with stroke. It is recommended 
that every diabetic patient should be routinely screened for albuminuria to prevent the disabling complication.
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O R I G I N A L  A R T I C L E
INTRODUCTION: Diabetes is causing burden on all 
health care systems around the world. It is estimated 
that global prevalence of diabetes in 2010 was 6.4%, 
affecting about 285 million adults, and will increase to 
7.7% in 2030 affecting about 439 million adults.1 
Prevalence of diabetes in Pakistan is 6 to 6.9% among 
males and 2.5 to 3.5% in females in different areas.2
Diabetes causes several vascular complications in 
patients categorized as macro and micro-vascular 
disorders. Common macrovascular problems include 
myocardial infarction, peripheral arterial diseases and 
stroke, whereas microvascular problems result in 
neuropathy, nephropathy and retinopathy.3 Prevalence 
of cerebrovascular disease in diabetics is 7% having 
2-3 times increased risk of fatal stroke as compared to 
general population.4 
Endothelial cell dysfunction and inflammation are key 
contributors to the development of stroke in diabetes 
mellitus.5 As albuminuria is considered a sign of 
endothelial dysfunction, and sub-clinical 
atherosclerosis, so presence of albuminuria is 
considered an important predictor of stroke.6 Diabetic 
nephropathy presenting as albuminuria is common in 
diabetics (about 34%), thus highlighting the increased 
risk of developing stroke.7
Close association between albuminuria and 
macrovascular complication like stroke has been 
reported in diabetic patients of Indian subcontinent.8 
The incidence of stroke varies with the level of 
albuminuria in diabetics. The higher urinary albumin 
excretion is associated with increased risk of 
developing stroke. The role of albuminuria as a 
predictor of stroke in diabetics need further studies to 
strengthen this association.9
MATERIALS AND METHODS
This was a hospital based descriptive cross-sectional 
study. 147 patients were included in the study that 
were admitted in the Department of Medicine, DHQ 
Teaching Hospital, Abbottabad, during the six months 
period from 15th April to 15th October 2017 and were 
diagnosed with stroke and were diabetic. 
Sample size was calculated using the WHO software to 
calculate the sample size taking confidence Level (1-α) 
at 95%, absolute precision 10, frequency of 
albuminuria in diabetic patients with stroke was kept as 
42.1%.10 Sample Size (n) came out to be 147. The 
sampling technique was nonprobability consecutive. 
The patients were of age 20 and above and either 
gender.
Prior approval from hospital ethical committee was 
taken. Use of data for research and publication was 
explained to the patients and/or their relatives, and 
informed consent was taken.
All patients fulfilling the inclusion criteria that have their 
diagnosis of stroke confirmed by neuroimaging (CT 
Scan or MRI) were included in the study.
Detailed history from the patients was taken and a 
complete physical examination was performed. 
Laboratory tests such as FBC, LFTs, renal profile, 
ultrasound abdomen and ECG was performed in all 
patients, included in the study, 24 hour urine 
collections was done by using a graduated standard jar 
and sent after 24 completed hours to detect 
albuminuria.  The patients with previous history of 
hypertension, smoking, valvular heart disease, atrial 
fibrillation, chronic renal failure and cirrhosis found on 
interview, physical examination or investigations were 
excluded from the study.
All the data was collected on a pre-designed proforma. 
Data was entered and analysed using SPSS-16. 
Continuous variables (e.g. age, 24 hours urinary 
albumin excretion) were described in terms of Mean 
and Standard Deviation. Frequencies and percentages 
were calculated for categorical variables like gender 
and Albuminuria. Albuminuria level was stratified 
among age and gender to see the effect modifications. 
All results were presented in the form of tables and 
graphs. Appearance of >30mg of albumin measured 
by 24 hour urinary protein in hospital laboratory was 
considered significant.
RESULTS
A total of 147 diabetic patients with stroke were 
included in this study. There were 93 (63.27%) males 
and 54(36.73%) females.
Seventeen of the patients were between 20-30 years 
(11.56%), while 19.73%(29) between 31-40 years, 
36.73%(n=54) between 41-50 years, and 
31.98%(n=47) between 51-60 years. The mean age 
was 43.65+4.24 years.
Frequency of albuminuria among diabetic patients 
presenting with stroke was 35.37%(n=52) (Table 1). 
59.62%(31) of these 52 patients were males and 
40.38%(21) were females (Figure 1). Out of these 52 
cases 4 (7.69%) were between 20-30 years, 
11(21.15%) between 31-40 years, 23(44.23%) 
between 41-50 years, and 14(26.93%) between 
51-60 years of age. (Figure 2)
 
Table 1: Frequency of albuminuria among
diabetic patients presenting with stroke.
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Figure 1: Frequency of albuminuria among diabetic 
patients presenting with stroke in age groups.
DISCUSSION
Diabetes mellitus is becoming a major contributor of 
morbidity and mortality in Pakistan. World Health 
Organization in its report shows that Pakistan has 5.2 
million diabetic subjects, and the number is expected 
to increase to a staggering 13.9 million making it the 
5th highest in the world by 2030.11
The recognition of frequency of microalbuminuria 
among diabetics presenting with stroke in our society 
was required so that we may timely manage the 
disease course, set a regular follow up criteria and save 
our patients from the morbidity.
Most of the patients in our study were between 41-50 
years of age i.e. 36.73%. These figures are in 
agreement with a study at Karachi with regards to 
prevalence of type II diabetes mellitus and diabetic 
retinopathy, which shows 58.32% of the patients 
between 30-40 years and the mean age was recorded 
as 42 years.12
In our study, frequency of albuminuria among diabetic 
patients presenting with stroke was 35.37%(n=52) 
while 64.63%(n=95) had no findings of the morbidity, 
these findings are in agreement with Nakamura T10 
who recorded these figures as 42.1%.  
Agaba EI and coworkers investigated the prevalence of 
microalbuminuria in newly diagnosed type 2 diabetic 
patients and its clinical correlation and found 
microalbuminuria  present in 32(49.2%) of the 
patients, and was significantly associated with mean 
arterial pressure, systemic hypertension and diabetic 
retinopathy (P < 0.05). Microalbuminuria is common 
in newly diagnosed patients with type 2 diabetes 
mellitus and suggested that routine screening for 
microalbuminuria as part of the initial evaluation of 
these patients.13
Microalbuminuria is common among patients with 
cerebrovascular disease and correlates with an 
increased stroke risk even after correction for 
confounding clinical risk factors. In the European 
Prospective Investigation into Cancer in Norfolk 
population, microalbuminuria was independently 
associated with a 50% increased risk for stroke (hazard 
ratio [HR] 1.49; 95% CI 1.13 to 2.14); the association 
with macroalbuminuria was even greater (HR 2.43; 
95% CI 1.11 to 6.26).14 In addition, a 15.5 year 
cohort study that examined stroke risk factors in Japan 
showed that urinary albumin was an independent risk 
factor for stroke in men (RR 2.5; 95% CI 1.1 to 5.7) 
but not in women.15
An association between microalbuminuria and 
recurrent stroke has also been reported. Among a 
population of older (median age 65 years) Americans 
with previous ischemic stroke or transient ischemic 
attack, microalbuminuria independently predicted 
future stroke (HR 4.9; 95% CI 1.4 to 17.6; P < 0.01 
versus patients with normoalbuminuria).16
Other reported cerebrovascular clinical correlates with 
microalbuminuria include cerebral ischemic lacunae, 
middle cerebral artery stenosis, impaired carotid 
arterial blood flow and vasomotor reactivity on Doppler 
ultrasonography, and increased carotid artery 
intima-media thickness. In addition, patients who have 
had an acute stroke and have microalbuminuria have a 
poorer outcome than those without 
microalbuminuria.17
Close association between albuminuria and 
macrovascular complication like stroke has been 
reported in diabetic patients of Indian subcontinent 
also.8 The incidence of stroke varies with the level of 
albuminuria in diabetics. The higher urinary albumin 
excretion is associated with increased risk of 
developing stroke.9
CONCLUSION
The frequency of albuminuria is high among diabetic 
patients presenting with stroke. Every patient who 
present with stroke with diabetes, should be checked 
out for albuminuria. It is also recommended that every 
diabetic patient should be routinely screened for 
albuminuria to prevent the disabling complication.
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The patients were of age 20 and above and either 
gender.
Prior approval from hospital ethical committee was 
taken. Use of data for research and publication was 
explained to the patients and/or their relatives, and 
informed consent was taken.
All patients fulfilling the inclusion criteria that have their 
diagnosis of stroke confirmed by neuroimaging (CT 
Scan or MRI) were included in the study.
Detailed history from the patients was taken and a 
complete physical examination was performed. 
Laboratory tests such as FBC, LFTs, renal profile, 
ultrasound abdomen and ECG was performed in all 
patients, included in the study, 24 hour urine 
collections was done by using a graduated standard jar 
and sent after 24 completed hours to detect 
albuminuria.  The patients with previous history of 
hypertension, smoking, valvular heart disease, atrial 
fibrillation, chronic renal failure and cirrhosis found on 
interview, physical examination or investigations were 
excluded from the study.
All the data was collected on a pre-designed proforma. 
Data was entered and analysed using SPSS-16. 
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albumin excretion) were described in terms of Mean 
and Standard Deviation. Frequencies and percentages 
were calculated for categorical variables like gender 
and Albuminuria. Albuminuria level was stratified 
among age and gender to see the effect modifications. 
All results were presented in the form of tables and 
graphs. Appearance of >30mg of albumin measured 
by 24 hour urinary protein in hospital laboratory was 
considered significant.
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(11.56%), while 19.73%(29) between 31-40 years, 
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between 41-50 years, and 14(26.93%) between 
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with macroalbuminuria was even greater (HR 2.43; 
95% CI 1.11 to 6.26).14 In addition, a 15.5 year 
cohort study that examined stroke risk factors in Japan 
showed that urinary albumin was an independent risk 
factor for stroke in men (RR 2.5; 95% CI 1.1 to 5.7) 
but not in women.15
An association between microalbuminuria and 
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developing stroke.9
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was required so that we may timely manage the 
disease course, set a regular follow up criteria and save 
our patients from the morbidity.
Most of the patients in our study were between 41-50 
years of age i.e. 36.73%. These figures are in 
agreement with a study at Karachi with regards to 
prevalence of type II diabetes mellitus and diabetic 
retinopathy, which shows 58.32% of the patients 
between 30-40 years and the mean age was recorded 
as 42 years.12
In our study, frequency of albuminuria among diabetic 
patients presenting with stroke was 35.37%(n=52) 
while 64.63%(n=95) had no findings of the morbidity, 
these findings are in agreement with Nakamura T10 
who recorded these figures as 42.1%.  
Agaba EI and coworkers investigated the prevalence of 
microalbuminuria in newly diagnosed type 2 diabetic 
patients and its clinical correlation and found 
microalbuminuria  present in 32(49.2%) of the 
patients, and was significantly associated with mean 
arterial pressure, systemic hypertension and diabetic 
retinopathy (P < 0.05). Microalbuminuria is common 
in newly diagnosed patients with type 2 diabetes 
mellitus and suggested that routine screening for 
microalbuminuria as part of the initial evaluation of 
these patients.13
Microalbuminuria is common among patients with 
cerebrovascular disease and correlates with an 
increased stroke risk even after correction for 
confounding clinical risk factors. In the European 
Prospective Investigation into Cancer in Norfolk 
population, microalbuminuria was independently 
associated with a 50% increased risk for stroke (hazard 
ratio [HR] 1.49; 95% CI 1.13 to 2.14); the association 
with macroalbuminuria was even greater (HR 2.43; 
95% CI 1.11 to 6.26).14 In addition, a 15.5 year 
cohort study that examined stroke risk factors in Japan 
showed that urinary albumin was an independent risk 
factor for stroke in men (RR 2.5; 95% CI 1.1 to 5.7) 
but not in women.15
An association between microalbuminuria and 
recurrent stroke has also been reported. Among a 
population of older (median age 65 years) Americans 
with previous ischemic stroke or transient ischemic 
attack, microalbuminuria independently predicted 
future stroke (HR 4.9; 95% CI 1.4 to 17.6; P < 0.01 
versus patients with normoalbuminuria).16
Other reported cerebrovascular clinical correlates with 
microalbuminuria include cerebral ischemic lacunae, 
middle cerebral artery stenosis, impaired carotid 
arterial blood flow and vasomotor reactivity on Doppler 
ultrasonography, and increased carotid artery 
intima-media thickness. In addition, patients who have 
had an acute stroke and have microalbuminuria have a 
poorer outcome than those without 
microalbuminuria.17
Close association between albuminuria and 
macrovascular complication like stroke has been 
reported in diabetic patients of Indian subcontinent 
also.8 The incidence of stroke varies with the level of 
albuminuria in diabetics. The higher urinary albumin 
excretion is associated with increased risk of 
developing stroke.9
CONCLUSION
The frequency of albuminuria is high among diabetic 
patients presenting with stroke. Every patient who 
present with stroke with diabetes, should be checked 
out for albuminuria. It is also recommended that every 
diabetic patient should be routinely screened for 
albuminuria to prevent the disabling complication.
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strengthen this association.9
MATERIALS AND METHODS
This was a hospital based descriptive cross-sectional 
study. 147 patients were included in the study that 
were admitted in the Department of Medicine, DHQ 
Teaching Hospital, Abbottabad, during the six months 
period from 15th April to 15th October 2017 and were 
diagnosed with stroke and were diabetic. 
Sample size was calculated using the WHO software to 
calculate the sample size taking confidence Level (1-α) 
at 95%, absolute precision 10, frequency of 
albuminuria in diabetic patients with stroke was kept as 
42.1%.10 Sample Size (n) came out to be 147. The 
sampling technique was nonprobability consecutive. 
The patients were of age 20 and above and either 
gender.
Prior approval from hospital ethical committee was 
taken. Use of data for research and publication was 
explained to the patients and/or their relatives, and 
informed consent was taken.
All patients fulfilling the inclusion criteria that have their 
diagnosis of stroke confirmed by neuroimaging (CT 
Scan or MRI) were included in the study.
Detailed history from the patients was taken and a 
complete physical examination was performed. 
Laboratory tests such as FBC, LFTs, renal profile, 
ultrasound abdomen and ECG was performed in all 
patients, included in the study, 24 hour urine 
collections was done by using a graduated standard jar 
and sent after 24 completed hours to detect 
albuminuria.  The patients with previous history of 
hypertension, smoking, valvular heart disease, atrial 
fibrillation, chronic renal failure and cirrhosis found on 
interview, physical examination or investigations were 
excluded from the study.
All the data was collected on a pre-designed proforma. 
Data was entered and analysed using SPSS-16. 
Continuous variables (e.g. age, 24 hours urinary 
albumin excretion) were described in terms of Mean 
and Standard Deviation. Frequencies and percentages 
were calculated for categorical variables like gender 
and Albuminuria. Albuminuria level was stratified 
among age and gender to see the effect modifications. 
All results were presented in the form of tables and 
graphs. Appearance of >30mg of albumin measured 
by 24 hour urinary protein in hospital laboratory was 
considered significant.
RESULTS
A total of 147 diabetic patients with stroke were 
included in this study. There were 93 (63.27%) males 
and 54(36.73%) females.
Seventeen of the patients were between 20-30 years 
(11.56%), while 19.73%(29) between 31-40 years, 
36.73%(n=54) between 41-50 years, and 
31.98%(n=47) between 51-60 years. The mean age 
was 43.65+4.24 years.
Frequency of albuminuria among diabetic patients 
presenting with stroke was 35.37%(n=52) (Table 1). 
59.62%(31) of these 52 patients were males and 
40.38%(21) were females (Figure 1). Out of these 52 
cases 4 (7.69%) were between 20-30 years, 
11(21.15%) between 31-40 years, 23(44.23%) 
between 41-50 years, and 14(26.93%) between 
51-60 years of age. (Figure 2)
 
Table 1: Frequency of albuminuria among
diabetic patients presenting with stroke.
primary care physicians of Pakistan in dealing with 
Figure 1: Frequency of albuminuria among diabetic 
patients presenting with stroke in age groups.
DISCUSSION
Diabetes mellitus is becoming a major contributor of 
morbidity and mortality in Pakistan. World Health 
Organization in its report shows that Pakistan has 5.2 
million diabetic subjects, and the number is expected 
to increase to a staggering 13.9 million making it the 
5th highest in the world by 2030.11
The recognition of frequency of microalbuminuria 
among diabetics presenting with stroke in our society 
was required so that we may timely manage the 
disease course, set a regular follow up criteria and save 
our patients from the morbidity.
Most of the patients in our study were between 41-50 
years of age i.e. 36.73%. These figures are in 
agreement with a study at Karachi with regards to 
prevalence of type II diabetes mellitus and diabetic 
retinopathy, which shows 58.32% of the patients 
between 30-40 years and the mean age was recorded 
as 42 years.12
In our study, frequency of albuminuria among diabetic 
patients presenting with stroke was 35.37%(n=52) 
while 64.63%(n=95) had no findings of the morbidity, 
these findings are in agreement with Nakamura T10 
who recorded these figures as 42.1%.  
Agaba EI and coworkers investigated the prevalence of 
microalbuminuria in newly diagnosed type 2 diabetic 
patients and its clinical correlation and found 
microalbuminuria  present in 32(49.2%) of the 
patients, and was significantly associated with mean 
arterial pressure, systemic hypertension and diabetic 
retinopathy (P < 0.05). Microalbuminuria is common 
in newly diagnosed patients with type 2 diabetes 
mellitus and suggested that routine screening for 
microalbuminuria as part of the initial evaluation of 
these patients.13
Microalbuminuria is common among patients with 
cerebrovascular disease and correlates with an 
increased stroke risk even after correction for 
confounding clinical risk factors. In the European 
Prospective Investigation into Cancer in Norfolk 
population, microalbuminuria was independently 
associated with a 50% increased risk for stroke (hazard 
ratio [HR] 1.49; 95% CI 1.13 to 2.14); the association 
with macroalbuminuria was even greater (HR 2.43; 
95% CI 1.11 to 6.26).14 In addition, a 15.5 year 
cohort study that examined stroke risk factors in Japan 
showed that urinary albumin was an independent risk 
factor for stroke in men (RR 2.5; 95% CI 1.1 to 5.7) 
but not in women.15
An association between microalbuminuria and 
recurrent stroke has also been reported. Among a 
population of older (median age 65 years) Americans 
with previous ischemic stroke or transient ischemic 
attack, microalbuminuria independently predicted 
future stroke (HR 4.9; 95% CI 1.4 to 17.6; P < 0.01 
versus patients with normoalbuminuria).16
Other reported cerebrovascular clinical correlates with 
microalbuminuria include cerebral ischemic lacunae, 
middle cerebral artery stenosis, impaired carotid 
arterial blood flow and vasomotor reactivity on Doppler 
ultrasonography, and increased carotid artery 
intima-media thickness. In addition, patients who have 
had an acute stroke and have microalbuminuria have a 
poorer outcome than those without 
microalbuminuria.17
Close association between albuminuria and 
macrovascular complication like stroke has been 
reported in diabetic patients of Indian subcontinent 
also.8 The incidence of stroke varies with the level of 
albuminuria in diabetics. The higher urinary albumin 
excretion is associated with increased risk of 
developing stroke.9
CONCLUSION
The frequency of albuminuria is high among diabetic 
patients presenting with stroke. Every patient who 
present with stroke with diabetes, should be checked 
out for albuminuria. It is also recommended that every 
diabetic patient should be routinely screened for 
albuminuria to prevent the disabling complication.
REFERENCES
1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates 
of the prevalence of diabetes for 2010 and 2030. 
Diabetes Res Clin Pract 2010;87:4-14.
2. Shera AS, Jawad F, Maqsood A. Prevalence of 
diabetes in Pakistan. Diabetes Res Clin Pract 
2007;76:219-22.
3. Stefanie Keymel, Yvonne Heinen, Jan Balzer, 
Tienush Rassaf, Malte Kelm, Thomas Lauer, and 
Christian Heiss. Characterization of macro-and 
microvascular function and structure in patients 
with type 2 diabetes mellitus.Am J Cardiovasc 
Dis2011;1: 68–75. 
4. Begley D, Cullen S, Davies C, Dhinoja M, Earley M, 
Graham J. Oxford handbook of cardiology. Punit 
Ramrakha and Jonathan Hill 2006; 140-1.
1 4P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 3  ( 4 )   O C T- D E C E M B E R  2 0 1 8
5. Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, 
Jaffa M, Jenkins AJ. Risk factors related  to 
inflammation  and  endothelial  dysfunction  in  the 
DCCT/EDIC  cohort  and  their relationship with 
nephropathy and macrovascular complications. 
Diabetes Care 2008;31:2006-12.
6. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, 
Ovbiagele B. Impact of microalbuminuria on 
incident stroke: a meta-analysis. Stroke 
2010;41:2625-31.
7. Meisinger C, Heier M, Landgraf R, Happich M, 
Wichmann HE, Piehlmeier W. Albuminuria, 
cardiovascular risk  factors and disease 
management in subjects with type 2 diabetes: a 
cross sectional study. BMC Health Serv Res 
2008;8:226.
8. Chandy A, Pawar B, John M, Isaac R. Association 
between diabetic nephropathy and other diabetic 
microvascular and macrovascular complications. 
Saudi J Kidney Dis Transpl 2008;19:924-8.
9. Lee M, Saver JL, Chang KH, Ovbiagele B. Level of 
albuminuria and risk of stroke. Cerebrovasc Dis 
2010;30:464-9.
10. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y. Silent 
cerebral infarction in patients with type 2 diabetic 
nephropathy. Effects of antiplatelet drug dilazep 
dihydrochloride. Diabetes Metab Res Rev. 
2005;21:39-43. 
11. Javadi MA, Katibeh M, Rafati N. Prevalence of 
diabetic retinopathy in Tehran province: a 
population-based study. BMC Ophthalmol. 
2009;16:9-12.
12. Mahar PS, Awan MZ, Manzar N, Memon MS. 
Prevalence of Type-II Diabetes Mellitus and 
Diabetic Retinopathy: The Gaddap Study. Journal 
of the College of Physicians and Surgeons 
Pakistan 2010;20(8):528-32.
13. Agaba EI, Agaba PA, Puepet FH. Prevalence of 
microalbuminuria in newly diagnosed type 2 
diabetic patients in Jos Nigeria. Afr J Med Med Sci. 
2004 Mar;33(1):19-22.
14. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham 
S, Day NE, Wareham NJ: Microalbuminuria and 
stroke in a British population: The European 
Prospective Investigation into Cancer in Norfolk 
(EPIC-Norfolk) population study. J Intern Med 
2004;255:247– 56.
15. Nakayama T, Date C, Yokoyama T, Yoshiike N, 
Yamaguchi M, Tanaka H: A 15.5-year follow-up 
study of stroke in a Japanese provincial city. The 
Shibata Study. Stroke 1997;28:45– 52.
16. Beamer NB, Coull BM, Clark WM, Wynn M: 
Microalbuminuria in ischemic stroke. Arch Neurol 
1999;56:699– 702. 
17. Slowik A, Turaj W, Iskra T, Strojny J, Szczudlik A: 
Microalbuminuria in nondiabetic patients with 
acute ischemic stroke: Prevalence, clinical 
correlates, and prognostic significance. 
Cerebrovasc Dis 2002;14:15– 21.
Conflict of interest: Author declares no conflict of interest. 
Funding disclosure: Nil
Author’s contribution:
Zahid Gul Jadoon; concept, data collection, data analysis, manuscript writing, manuscript review
Raheel Jahangir Jadoon;  data collection, data analysis, manuscript writing
Mir Jalal-ud-din; concept, data collection, data analysis, manuscript writing, manuscript review
Nayab Balqees; data collection,manuscript writing, manuscript review
Muhammad Munir Noor; data analysis, manuscript writing, manuscript review
Syed Affan Ali; data collection, data analysis, manuscript writing, manuscript review
